Last A$67.53 AUD
Change Today +0.43 / 0.64%
Volume 1.1M
CSL On Other Exchanges
Symbol
Exchange
OTC US
Munich
OTC US
As of 2:10 AM 04/16/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

John Shine AO, FAA, Ph.D., BSc

Chairman, Chairman of Nomination Committee, Member of Innovation & Development Committee, Member of Funding Committee and Member of Capital Structuring Committee, CSL Ltd.
AgeTotal Calculated CompensationThis person is connected to 12 board members in 2 different organizations across 4 different industries.

See Board Relationships
67$589,618

Background*

Professor John Shine, Ao FAA, Ph.D., BSc, serves as the Chief Executive Officer of Garvan Chairman of Institute of Medical Research. Prof. Shine is a Professor of Molecular Biology and Professor of Medicine at the University of NSW. He serves as Secretary (Biological Sciences) of the Australian Academy of Science. He is an Australian molecular biology and biotechnology pioneer. He has been the Chairman of CSL Ltd. since October 19, 2011 and serves as its a Non Executive ...

Read Full Background

Corporate Headquarters*

45 Poplar Road
Parkville, Victoria 3052

Australia

Phone: 61 3 9389 1911
Fax: 61 3 9389 1434

Board Members Memberships*

Former Director
Director
2000-N/A
Former Director
2006-Present
Chairman, Chairman of Nomination Committee, Member of Innovation & Development Committee, Member of Funding Committee and Member of Capital Structuring Committee

Education*

There is no Education data available.

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Annual Cash Compensation$589,618
Total Calculated Compensation$589,618
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CSL:AU A$67.53 AUD +0.43

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
George A. Scangos Ph.D.Chief Executive Officer and Director
Biogen Idec Inc.
$1.3M
Flemming Ornskov M.D., MBA, MPHChief Executive Officer and Director
Shire plc
$2.7M
Victor Grifols Roura Chairman, Chief Executive Officer, President, Managing Director and Member of Appointments & Remuneration Committee
Grifols, S.A.
--
Yoshihiko Hatanaka Chief Executive Officer, President and Representative Director
Astellas Pharma, Inc.
--
Kiran Mazumdar-Shaw B.Sc (Hons), PGD in Malting & BrewingFounder, Chairman, Managing Director, Member of Share Transfer Committee and Member of Investor Grievances Committee
Biocon Limited
13.2M
Compensation as of Fiscal Year 2012.

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CSL LTD, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.